Brexit – guidance to stakeholders on impact in the field of Good Laboratory Practice (GLP), Published on: 28/06/2019brexitUK

In view of the uncertainties surrounding the ratification of the Withdrawal Agreement, all interested parties, and especially economic operators, are reminded of legal repercussions, which need to be considered when the United Kingdom becomes a third country.

This document analyses the legal consequences of the United Kingdom's withdrawal on Good Laboratory Practice (GLP).


See also:

the Practical guidance for procedures related to Brexit for medicinal products for human use approved via MRP/DCP and Questions & Answers.

EMA: Brexit-related guidance for companies